Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs.
Cell Prolif. 2020 Dec;53(12):e12944. doi: 10.1111/cpr.12944. Epub 2020 Oct 26.
Cell Prolif. 2020.
PMID: 33107132
Free PMC article.
Clinical Trial.
No abstract available.
First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells.
Wu J, Hu Z, Wang L, Tan Y, Hou W, Li Z, Gao T, Fan J, Guo B, Dai H, Li W, Hao J, Jin R, Hu B.
Wu J, et al.
Cell Prolif. 2020 Dec;53(12):e12943. doi: 10.1111/cpr.12943. Epub 2020 Oct 26.
Cell Prolif. 2020.
PMID: 33107123
Free PMC article.
No abstract available.
Item in Clipboard
Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis.
Li Z, Niu S, Guo B, Gao T, Wang L, Wang Y, Wang L, Tan Y, Wu J, Hao J.
Li Z, et al.
Cell Prolif. 2020 Dec;53(12):e12939. doi: 10.1111/cpr.12939. Epub 2020 Oct 24.
Cell Prolif. 2020.
PMID: 33098357
Free PMC article.
Review.
Item in Clipboard
Intra-articular delivery of umbilical cord-derived mesenchymal stem cells temporarily retard the progression of osteoarthritis in a rat model.
Xing D, Wu J, Wang B, Liu W, Liu W, Zhao Y, Wang L, Li JJ, Liu A, Zhou Q, Hao J, Lin J.
Xing D, et al.
Int J Rheum Dis. 2020 Jun;23(6):778-787. doi: 10.1111/1756-185X.13834. Epub 2020 Apr 21.
Int J Rheum Dis. 2020.
PMID: 32319197
Item in Clipboard
Cite
Cite